Controlled Delivery of (-)-Epigallocatechin 3-Gallate as a Therapeutic Strategy for the Degenerative Disc Disease

Degenerative disc disease (DDD) is the accelerated process of intervertebral disc decay (decrease of disc thickness, enhanced cell death, ECM damage and collagen loss etc.), accompanied with pain, as well as structural and functional failure. So far, there are no therapies that can inhibit or even reverse the degenerative progress of this...